Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of Mofecon were conducted, in this meeting which was held in the presence of respected professors of Nephrology on Wednesday, 03/17/1402, in Lebafinejad Hospital. Based on this meeting’s assessment, Mofecon is bioequivalent to the originator.
Shahid Madani Tabriz Heart Center morning meeting was held on july 23, 1400 on the role of Ticagrelor. in the treatment of Acute Coronary Syndrome and presentation of clinical studies. This meeting was held in the presence of respected professors, including: Interventionist: Dr.Separham, Dr.Ghaffari Dr.Aslan Abadi Dr.Sohrabi Electrophysiologist: Dr.Abbas Nezhad